These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Standardization of the diffusion method of determining the biological activity of polyene antibiotics]. Vasil'eva NG, Fradkova TA, Bershteĭn EM, Golubkova LS, Poliak MS. Tr Inst Im Pastera; 1982; 58():117-9. PubMed ID: 7187546 [No Abstract] [Full Text] [Related]
24. In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens. Ellabib MS, ElJariny IA. Saudi Med J; 2001 Oct; 22(10):860-3. PubMed ID: 11744942 [Abstract] [Full Text] [Related]
25. [Photostability of antifungal agents. 2. Photostability of polyene antibiotics]. Thoma K, Kübler N. Pharmazie; 1997 Apr; 52(4):294-302. PubMed ID: 9190607 [Abstract] [Full Text] [Related]
26. Antifungal activity of local anesthetics against Candida species. Pina-Vaz C, Rodrigues AG, Sansonetty F, Martinez-De-Oliveira J, Fonseca AF, Mårdh PA. Infect Dis Obstet Gynecol; 2000 Apr; 8(3-4):124-37. PubMed ID: 10968594 [Abstract] [Full Text] [Related]
31. Interaction between nystatin and natural membrane lipids in Langmuir monolayers--the role of a phospholipid in the mechanism of polyenes mode of action. Hac-Wydro K, Dynarowicz-Latka P. Biophys Chem; 2006 Sep 20; 123(2-3):154-61. PubMed ID: 16766114 [Abstract] [Full Text] [Related]
32. [Modern concepts of the mechanism of action of polyene antibiotics: the interrelation of structure and function]. Kasumov KhM. Antibiotiki; 1981 Feb 20; 26(2):143-55. PubMed ID: 6260027 [No Abstract] [Full Text] [Related]
33. Magnetic nanoparticles as a drug delivery system that enhance fungicidal activity of polyene antibiotics. Niemirowicz K, Durnaś B, Tokajuk G, Głuszek K, Wilczewska AZ, Misztalewska I, Mystkowska J, Michalak G, Sodo A, Wątek M, Kiziewicz B, Góźdź S, Głuszek S, Bucki R. Nanomedicine; 2016 Nov 20; 12(8):2395-2404. PubMed ID: 27464757 [Abstract] [Full Text] [Related]
34. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole. Lignell A, Johansson A, Löwdin E, Cars O, Sjölin J. Clin Microbiol Infect; 2007 Jun 20; 13(6):613-9. PubMed ID: 17378925 [Abstract] [Full Text] [Related]
35. Arachidonic acid increases antifungal susceptibility of Candida albicans and Candida dubliniensis. Ells R, Kock JL, Van Wyk PW, Botes PJ, Pohl CH. J Antimicrob Chemother; 2009 Jan 20; 63(1):124-8. PubMed ID: 18971215 [Abstract] [Full Text] [Related]
38. Isolation of intact lysosomes from human RPE cells and effects of A2-E on the integrity of the lysosomal and other cellular membranes. Schütt F, Bergmann M, Holz FG, Kopitz J. Graefes Arch Clin Exp Ophthalmol; 2002 Dec 20; 240(12):983-8. PubMed ID: 12483320 [Abstract] [Full Text] [Related]
39. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans. De Logu A, Saddi M, Cardia MC, Borgna R, Sanna C, Saddi B, Maccioni E. J Antimicrob Chemother; 2005 May 20; 55(5):692-8. PubMed ID: 15772140 [Abstract] [Full Text] [Related]